These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2783952)

  • 1. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
    Ashworth J; Kahan MC; Breathnach SM
    J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
    Ashworth J; Booker J; Breathnach SM
    Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency classification of topical corticosteroids: modern perspectives.
    Ashworth J
    Acta Derm Venereol Suppl (Stockh); 1989; 151():20-5; discussion 47-52. PubMed ID: 2696307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation.
    Cooper KD; Neises GR; Katz SI
    J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis and sorting of HLA-DR+CD1+ Langerhans cells.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Jul; 121(1):11-8. PubMed ID: 2474321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
    Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased number and function of antigen-presenting cells in the skin following application of irritant agents: relevance for skin cancer?
    Lisby S; Baadsgaard O; Cooper KD; Vejlsgaard GL
    J Invest Dermatol; 1989 Jun; 92(6):842-7. PubMed ID: 2786039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
    de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
    J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous detection of T6 and HLA-DR antigens distinguishes three cell subpopulations in dispersed normal human epidermal cells.
    Dezutter-Dambuyant C; Faure M; Schmitt D; Laquoi C; Thivolet J
    Immunol Lett; 1984; 7(4):203-7. PubMed ID: 6423529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells expressing HLA-DQ, HLA-DR and T6 antigens in normal oral mucosa and lichen planus.
    Chou MJ; Daniels TE
    J Oral Pathol Med; 1989 Dec; 18(10):573-6. PubMed ID: 2621652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose response and time course for induction of T6- DR+ human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiation.
    Baadsgaard O; Cooper KD; Lisby S; Wulf HC; Wantzin GL
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):792-800. PubMed ID: 3500191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: initial depression of Langerhans cell-dependent function is followed by the appearance of T6- Dr+ cells that enhance epidermal alloantigen presentation.
    Cooper KD; Fox P; Neises G; Katz SI
    J Immunol; 1985 Jan; 134(1):129-37. PubMed ID: 3964811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
    Sontheimer RD
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
    Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous colloidal gold immunoelectronmicroscopy labeling of CD1a, HLA-DR, and CD4 surface antigens of human epidermal Langerhans cells.
    De Panfilis G; Manara GC; Ferrari C; Torresani C
    J Invest Dermatol; 1988 Dec; 91(6):547-52. PubMed ID: 3263998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR+/T6- Langerhans cells of the human cornea.
    Seto SK; Gillette TE; Chandler JW
    Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1719-22. PubMed ID: 3498703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Despite the presence of UVB-induced DNA damage, HLA-DR+ cells from ex vivo UVB-exposed human skin are able to migrate and show no impaired allostimulatory capacity.
    Kremer IB; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Invest Dermatol; 1997 Nov; 109(5):626-31. PubMed ID: 9347789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1a and CD1c cell sorting yields a homogeneous population of immature human Langerhans cells.
    Peiser M; Grützkau A; Wanner R; Kolde G
    J Immunol Methods; 2003 Aug; 279(1-2):41-53. PubMed ID: 12969546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.